Page last updated: 2024-11-05

thenoyltrifluoroacetone and Leukemia, Prolymphocytic

thenoyltrifluoroacetone has been researched along with Leukemia, Prolymphocytic in 1 studies

Thenoyltrifluoroacetone: Chelating agent and inhibitor of cellular respiration.

Leukemia, Prolymphocytic: A chronic leukemia characterized by a large number of circulating prolymphocytes. It can arise spontaneously or as a consequence of transformation of CHRONIC LYMPHOCYTIC LEUKEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gamen, S1
Anel, A1
Montoya, J1
Marzo, I1
PiƱeiro, A1
Naval, J1

Other Studies

1 other study available for thenoyltrifluoroacetone and Leukemia, Prolymphocytic

ArticleYear
mtDNA-depleted U937 cells are sensitive to TNF and Fas-mediated cytotoxicity.
    FEBS letters, 1995, Nov-27, Volume: 376, Issue:1-2

    Topics: Amobarbital; Antibodies; Apoptosis; Base Sequence; Cell Division; Cell Line; DNA, Mitochondrial; Doc

1995